Congenital nephrogenic diabetes insipidus: the current state of affairs.
about
The Trafficking of the Water Channel Aquaporin-2 in Renal Principal Cells-a Potential Target for Pharmacological Intervention in Cardiovascular DiseasesA novel therapeutic effect of statins on nephrogenic diabetes insipidusProtein trafficking defects in inherited kidney diseasesX-ray structure of human aquaporin 2 and its implications for nephrogenic diabetes insipidus and traffickingAltered agonist sensitivity of a mutant v2 receptor suggests a novel therapeutic strategy for nephrogenic diabetes insipidus.Aquaporins: important but elusive drug targets.Combination of secretin and fluvastatin ameliorates the polyuria associated with X-linked nephrogenic diabetes insipidus in mice.High-throughput chemical screening identifies AG-490 as a stimulator of aquaporin 2 membrane expression and urine concentrationClinical overview of nephrogenic diabetes insipidus based on a nationwide survey in Japan.Protein traffic disorders: an effective high-throughput fluorescence microscopy pipeline for drug discovery.Novel autosomal recessive gene mutations in aquaporin-2 in two Chinese congenital nephrogenic diabetes insipidus pedigrees.Diagnosis of diabetes insipidus observed in Swiss Duroc boarsNephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment.Soluble (pro)renin receptor via β-catenin enhances urine concentration capability as a target of liver X receptor.β3 adrenergic receptor in the kidney may be a new player in sympathetic regulation of renal functionLysosome dysfunction in the pathogenesis of kidney diseases.The long-term complications of the inherited tubulopathies: an adult perspective.Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus.ILK and cytoskeletal architecture: an important determinant of AQP2 recycling and subsequent entry into the exocytotic pathway.Small-molecule screening identifies modulators of aquaporin-2 trafficking.Novel de novo AVPR2 Variant in a Patient with Congenital Nephrogenic Diabetes Insipidus.Severe Hypernatremia and Failure to Thrive.Functional characterization of AVPR2 mutants found in Turkish patients with nephrogenic diabetes insipidus.Pharmacological Chaperones as Potential Therapeutic Strategies for Misfolded Mutant Vasopressin Receptors.Hereditary Nephrogenic Diabetes Insipidus: Pathophysiology and Possible Treatment. An Update.Expanding the role of vasopressin antagonism in polycystic kidney diseases: From adults to children?AKAPs-PKA disruptors increase AQP2 activity independently of vasopressin in a model of nephrogenic diabetes insipidus.A novel AVPR2 splice site mutation leads to partial X-linked nephrogenic diabetes insipidus in two brothers.Structural Basis for Mutations of Human Aquaporins Associated to Genetic Diseases.
P2860
Q26768170-68D61611-C1E5-490D-88ED-74C36152FF71Q27005638-2DAF8307-25A2-4977-AC2C-C388EC2C1275Q27012909-1B7E3D18-FC5F-41C4-944A-F6B5FFD9F99FQ27683366-52E3B984-89B8-4D8A-9412-75A1C009CE03Q33632079-210571DB-4828-4BDD-8C3E-3228D81B9DEAQ33792739-3B718784-81C5-4FDD-8C43-8BCC63FB301FQ33840550-F768F5CD-4235-4CC6-B5AF-5FA6E922ECB4Q34295359-1A97DD8F-AFD4-41A3-83BF-60314C83E99FQ34345836-68B821AE-E351-4553-8AAF-937E0226E10DQ35575499-A8B34749-B0D6-4A18-BBBD-2D83057E1191Q35643644-78D3668F-906E-432F-B540-441F6D31E4FBQ35910962-4370B180-7AF3-4616-9284-6B413D155F6DQ36724058-4700E823-E680-4C2F-9255-BC57386421C5Q36770595-C76209F2-9861-447B-98E1-61445C0C265CQ37201204-8CAB1B38-1D93-4A97-8A7D-F9B9CC4EBE0CQ38161818-C2A67A69-8D1B-4584-A8FB-B677BE3E5ADCQ38190864-65084FB4-8FAA-404D-8F34-0C5A3559A607Q38528569-B81EA887-84B3-4CB3-A80F-4433B91FE995Q38739650-71C1DE38-B0E4-492A-B041-7C9381CF2E58Q40128897-5BEE5A6D-AAF6-469D-9238-1A56E07D0214Q45843545-EC4F0870-F8B1-4EBD-BDBA-198A8399063AQ46173296-22FBA568-5923-4331-8FF7-E3B67DA88721Q47096802-37EF98C3-F8A4-4433-8438-63F07DA8DA4AQ47757944-6EFBC03E-47BC-4C6B-8809-F46D0AD83FF0Q47802729-3A60BCBB-CBC3-43DC-A1E8-4B572A8AA6F0Q48216298-96670C14-1937-44E8-AB7E-DD3BE456CDADQ52691158-63D96D42-E823-47CA-9E2F-80EAD95953EDQ52887876-977E8EFC-F385-4FA9-97D8-EF73EC2E8D23Q55613491-44ADCBBD-8CE6-46B4-ACA9-F7E44DD33C08
P2860
Congenital nephrogenic diabetes insipidus: the current state of affairs.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Congenital nephrogenic diabetes insipidus: the current state of affairs.
@en
Congenital nephrogenic diabetes insipidus: the current state of affairs.
@nl
type
label
Congenital nephrogenic diabetes insipidus: the current state of affairs.
@en
Congenital nephrogenic diabetes insipidus: the current state of affairs.
@nl
prefLabel
Congenital nephrogenic diabetes insipidus: the current state of affairs.
@en
Congenital nephrogenic diabetes insipidus: the current state of affairs.
@nl
P2093
P2860
P1433
P1476
Congenital nephrogenic diabetes insipidus: the current state of affairs.
@en
P2093
Daniel Wesche
Nine V A M Knoers
Peter M T Deen
P2860
P2888
P304
P356
10.1007/S00467-012-2118-8
P577
2012-03-17T00:00:00Z